News | January 06, 2009

CTO Summit Set for Feb 5-6 in New York

January 7, 2009 - The Sixth International Chronic Total Occlusion Summit is Feb. 5-6, at the New York Marriott Marquis Hotel in the heart of Times Square at 1535 Broadway, New York, NY.

Chronic total occlusions (CTOs) of coronary arteries represent one of the greatest challenges to interventional cardiologists. Successful revascularization of CTOs has been strongly associated with improved left ventricular function, freedom from angina and future revascularization, and in several studies increased survival.

This year's CTO Summit will include presentations from experts in the field, case review sessions, and numerous thematically organized live coronary CTO cases broadcast in high definition from Scripps Clinic and Research Foundation in La Jolla, CA, and Columbia University Medical Center in New York, NY.

For more information: www.ctosummit.org


Related Content

News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
Subscribe Now